Form 8-K - Current report:
SEC Accession No. 0001193125-25-103761
Filing Date
2025-04-29
Accepted
2025-04-29 16:05:20
Documents
39
Period of Report
2025-04-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d938753d8k.htm   iXBRL 8-K 26028
2 EX-99.1 d938753dex991.htm EX-99.1 35575
6 GRAPHIC g938753ex99_1p10g1.jpg GRAPHIC 291522
7 GRAPHIC g938753ex99_1p11g1.jpg GRAPHIC 325668
8 GRAPHIC g938753ex99_1p12g1.jpg GRAPHIC 278142
9 GRAPHIC g938753ex99_1p13g1.jpg GRAPHIC 340994
10 GRAPHIC g938753ex99_1p14g1.jpg GRAPHIC 355427
11 GRAPHIC g938753ex99_1p15g1.jpg GRAPHIC 252875
12 GRAPHIC g938753ex99_1p16g1.jpg GRAPHIC 298714
13 GRAPHIC g938753ex99_1p17g1.jpg GRAPHIC 338042
14 GRAPHIC g938753ex99_1p18g1.jpg GRAPHIC 316585
15 GRAPHIC g938753ex99_1p19g1.jpg GRAPHIC 333136
16 GRAPHIC g938753ex99_1p1g1.jpg GRAPHIC 160171
17 GRAPHIC g938753ex99_1p20g1.jpg GRAPHIC 311245
18 GRAPHIC g938753ex99_1p21g1.jpg GRAPHIC 118204
19 GRAPHIC g938753ex99_1p22g1.jpg GRAPHIC 225416
20 GRAPHIC g938753ex99_1p23g1.jpg GRAPHIC 257459
21 GRAPHIC g938753ex99_1p24g1.jpg GRAPHIC 253492
22 GRAPHIC g938753ex99_1p25g1.jpg GRAPHIC 153939
23 GRAPHIC g938753ex99_1p2g1.jpg GRAPHIC 602063
24 GRAPHIC g938753ex99_1p3g1.jpg GRAPHIC 257413
25 GRAPHIC g938753ex99_1p4g1.jpg GRAPHIC 147836
26 GRAPHIC g938753ex99_1p5g1.jpg GRAPHIC 275752
27 GRAPHIC g938753ex99_1p6g1.jpg GRAPHIC 317183
28 GRAPHIC g938753ex99_1p7g1.jpg GRAPHIC 338331
29 GRAPHIC g938753ex99_1p8g1.jpg GRAPHIC 348948
30 GRAPHIC g938753ex99_1p9g1.jpg GRAPHIC 341164
  Complete submission text file 0001193125-25-103761.txt   10178766

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jbio-20250429.xsd EX-101.SCH 2505
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jbio-20250429_lab.xml EX-101.LAB 19452
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jbio-20250429_pre.xml EX-101.PRE 12129
42 EXTRACTED XBRL INSTANCE DOCUMENT d938753d8k_htm.xml XML 4030
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 25887116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)